The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCTEA.L Regulatory News (CTEA)

  • There is currently no data for CTEA

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director and PDMR remuneration - Conversion

27 Jul 2021 07:00

RNS Number : 5128G
Catenae Innovation PLC
27 July 2021
 

27 July 2021

 

Catenae Innovation PLC

("Catenae" or the "Company")

 

Director and PDMR remuneration - Conversion

 

Catenae Innovation PLC (AIM: CTEA), the AIM quoted provider of digital media and technology, announces that the Board has agreed to settle certain existing director and PDMR remuneration liabilities through the conversion of accrued salaries and expenses into new ordinary shares as per the Company's previously stated policy announced on 24 April 2020. The previous conversion of director remuneration into ordinary shares by certain directors was announced on 27 January 2021. The rationale for the conversion into shares is to preserve the existing cash resources of the Company.

 

Guy Meyer and John Farthing, Chief Executive Officer and Chief Financial Officer of the Company respectively, will settle a portion of their remuneration up to 31 August 2021 and will continue receiving shares in lieu of salary on a six month basis.

 

Guy Meyer and John Farthing1 will respectively receive £20,002.20 and £4,702.14 in shares in lieu of payroll liabilities to 31 August 2021 and the Company's Chief Commercial Officer (non-Board role), Nick Delacamp, will receive £1,323.69 in shares to settle expense liabilities up to 31 August 2021 (the "Conversion"). The issue of shares pursuant to the Conversion will be issued at a price equal to the 30-day volume weighted average price per share ("VWAP") to 31 August 2021.

 

Furthermore, following the issue of new ordinary shares, Guy Meyer intends to transfer £20,000 worth of shares received in lieu of remuneration to an ISA account in his name.

 

A further announcement will be made in due course in relation to the issue of new ordinary shares in the Company.

 

1John Farthing's shareholdings are held through Cloisters Capital LLP

 

- Ends -

 

This announcement contains inside information for the purposes of the UK Market Abuse Regulation. The person who arranged for release of this announcement on behalf of the Company was Guy Meyer, Chief Executive Officer of the Company and the Directors of the Company are responsible for the release of this announcement.

 

 

 

For further information please contact:

Catenae Innovation PLC

+44 (0)191 580 8545

Guy Meyer, Chief Executive Officer

 

Cairn Financial Advisers LLP (Nominated Adviser)

+44(0)20 7213 0880

Liam Murray / Jo Turner

 

Brandon Hill Capital Limited, Broker

+44 (0)20 3463 5000

Andy Gutmann

 

 

Yellow Jersey PR (PR & IR)

+44 (0)20 3004 9512

Sarah Hollins / Annabel Atkins / Matthew McHale

 

Notes to Editors:

About Catenae Innovation PLC

Catenae Innovation is an AIM quoted provider of digital media and technology services. Catenae use the power of blockchain to deliver solutions where its people-centric technology enables trust and certainty allowing organisations to gain better control over their operations, manage staff and safely welcome customers.

www.catenaeinnovation.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUNANRANUBUAR
Date   Source Headline
6th Sep 20193:28 pmRNSHolding(s) in Company
18th Jul 201912:18 pmGNWCatenae Innovation Plc: Directorate change
15th Jul 20193:55 pmGNWCatenae Innovation Plc: Director’s Dealing
28th Jun 20197:00 amGNWCatenae Innovation Plc: Half-year report
22nd May 20197:00 amGNWCatenae Innovation Plc: Company Update and Issue of Equity
25th Apr 201912:33 pmGNWCatenae Innovation Plc: Result of General Meeting
1st Apr 20194:30 pmGNWCatenae Innovation Plc: Notice of General Meeting
14th Mar 20191:44 pmGNWCatenae Innovation Plc: Holding(s) in Company
27th Feb 20197:00 amGNWCatenae Innovation Plc: Placing, Appointment of Joint Broker, Issue of Warrants and Related Party Transaction
5th Feb 201911:05 amRNSSecond Price Monitoring Extn
5th Feb 201911:00 amRNSPrice Monitoring Extension
5th Feb 20197:00 amGNWCatenae Innovation Plc: Licence Framework Agreement Signed
1st Feb 201912:05 pmGNWCatenae Innovation Plc: Result of AGM
1st Feb 20197:00 amGNWCatenae Innovation Plc: Company Update
25th Jan 20197:00 amGNWCatenae Innovation Plc: Agreement Signed
24th Jan 20197:00 amGNWCatenae Innovation Plc: Company Update
21st Jan 20197:00 amGNWCatenae Innovation Plc: OnSite - Contract Signed
9th Jan 20194:00 pmGNWCatenae Innovation Plc: Posting of Report and Accounts and Notice of Annual General Meeting
31st Dec 20187:00 amGNWCatenae Innovation Plc: Final Results
6th Dec 20187:00 amGNWCatenae Innovation Plc: Contract and Product Update
9th Nov 20181:55 pmGNWCatenae Innovation Plc: Update on Holding(s) in Company
8th Nov 201810:51 amGNWCatenae Innovation Plc: Holding(s) in Company
8th Nov 201810:50 amGNWCatenae Innovation Plc: Holding(s) in Company
1st Nov 20187:00 amGNWCatenae Innovation Plc: Issue of Equity
22nd Oct 20187:00 amGNWCatenae Innovation Plc: Signed Agreement with Southend United Football Club
18th Dec 200912:29 pmRNSDirector/PDMR Shareholding
7th Aug 20093:16 pmRNSAcquisition of further interest in Minds+Machines
27th Nov 200811:30 amRNSSubscription
29th Sep 200811:16 amRNSNew Sports Venture Shareholders Agreement
19th Sep 20087:00 amRNSLoan Note Conversion
12th Sep 20087:00 amRNSFacilities Supply Agreement
3rd Sep 200811:13 amRNSDisposal
6th Aug 20087:00 amRNSNOTIFICATION OF MAJOR INTERES
31st Jul 200811:43 amRNSResult of Meeting
15th Jul 20084:38 pmRNSHolding(s) in Company
10th Jul 20082:35 pmRNSHolding(s) in Company
8th Jul 20087:00 amRNSCapital Reorganisation and Su
30th Jun 20087:28 amRNSInterim Results
14th May 20088:00 amRNSHolding(s) in Company
30th Apr 20083:47 pmRNSAGM Statement
1st Apr 20082:57 pmRNSAnnual Report and Accounts
31st Mar 20085:41 pmRNSFinal Results
7th Mar 200810:14 amRNSDirectorate Change
15th Jan 20083:48 pmRNSAcquisition
11th Dec 20073:58 pmRNSHolding(s) in Company
7th Dec 200710:39 amRNSHolding(s) in Company
6th Dec 200711:42 amRNSHolding(s) in Company
5th Dec 200710:33 amRNSHolding(s) in Company
28th Nov 20075:08 pmRNSHolding(s) in Company
28th Nov 20077:01 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.